CLINICAL_TRIALS
trial_result
· 2024-04-29
Clinical Trial Update: A Long-Term Study of Brexpiprazole in Patients With Major Depressive Disorder [Phase 3]
Summary
A Phase 3 long-term study of brexpiprazole in adults with major depressive disorder has completed, with results posted in April 2024.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Otsuka Pharmaceutical Co., Ltd. | Conditions: Major Depressive Disorder | Phase 3 | Status: COMPLETED | Results posted: 2024-04-29